en Experimental Neurobiology

Cited by CrossRef (29)

  1. 霖苑 郭. Effects of Different Pre-Harvest Blue Light Supply Methods on Growth and Quality of Lettuce. HJAS 2021;11:919
    https://doi.org/10.12677/HJAS.2021.1110122
  2. Julia J. Meerman, Juliette Legler, Aldert H. Piersma, Remco H.S. Westerink, Harm J. Heusinkveld. An adverse outcome pathway for chemical-induced Parkinson’s disease: Calcium is key. NeuroToxicology 2023;99:226
    https://doi.org/10.1016/j.neuro.2023.11.001
  3. Kathryn M. Miller, Joseph R. Patterson, Joseph Kochmanski, Christopher J. Kemp, Anna C. Stoll, Christopher U. Onyekpe, Allyson Cole-Strauss, Kathy Steece-Collier, Jacob W. Howe, Kelvin C. Luk, Caryl E. Sortwell. Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS. J. Neurosci. 2021;41:2039
    https://doi.org/10.1523/JNEUROSCI.1952-20.2020
  4. Nicolas Giguère, Samuel Burke Nanni, Louis-Eric Trudeau. On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. Front. Neurol. 2018;9
    https://doi.org/10.3389/fneur.2018.00455
  5. Li Meng, Hongyu Wang, Ting Zou, Xuyang Wang, Huafu Chen, Fangfang Xie, Rong Li. Attenuated brain white matter functional network interactions in Parkinson's disease. Human Brain Mapping 2022;43:4567
    https://doi.org/10.1002/hbm.25973
  6. Thomas Musacchio, Jing Yin, Fabian Kremer, James B. Koprich, Jonathan M. Brotchie, Jens Volkmann, Chi Wang Ip. Temporal, spatial and molecular pattern of dopaminergic neurodegeneration in the AAV-A53T α-synuclein rat model of Parkinson’s disease. Behavioural Brain Research 2022;432:113968
    https://doi.org/10.1016/j.bbr.2022.113968
  7. Erlei Wang, Yujing Jia, Yang Ya, Jin Xu, Chengjie Mao, Weifeng Luo, Guohua Fan, Zhen Jiang. Patterns of Sulcal depth and cortical thickness in Parkinson’s disease. Brain Imaging and Behavior 2021;15:2340
    https://doi.org/10.1007/s11682-020-00428-x
  8. Magdalena K. Baaske, Edgar R. Kramer, Durga Praveen Meka, Gerhard Engler, Andreas K. Engel, Christian K.E. Moll. Parkin deficiency perturbs striatal circuit dynamics. Neurobiology of Disease 2020;137:104737
    https://doi.org/10.1016/j.nbd.2020.104737
  9. Dylan J. Dues, An Phu Tran Nguyen, Katelyn Becker, Jiyan Ma, Darren J. Moore. Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction. npj Parkinsons Dis. 2023;9
    https://doi.org/10.1038/s41531-023-00574-1
  10. Abeer Dagra, Douglas R. Miller, Min Lin, Adithya Gopinath, Fatemeh Shaerzadeh, Sharonda Harris, Zachary A. Sorrentino, Jonatan Fullerton Støier, Sophia Velasco, Janelle Azar, Adetola R. Alonge, Joseph J. Lebowitz, Brittany Ulm, Mengfei Bu, Carissa A. Hansen, Nikhil Urs, Benoit I. Giasson, Habibeh Khoshbouei. α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability. npj Parkinsons Dis. 2021;7
    https://doi.org/10.1038/s41531-021-00210-w
  11. R.T. Bartus, J.H. Kordower, E.M. Johnson, L. Brown, B.R. Kruegel, Y. Chu, T.L. Baumann, A.E. Lang, C.W. Olanow, C.D. Herzog. Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies. Neurobiology of Disease 2015;78:162
    https://doi.org/10.1016/j.nbd.2015.03.023
  12. Kelley C. O'Donnell, Aaron Lulla, Mark C. Stahl, Nickolas D. Wheat, Jeff M. Bronstein, Alvaro Sagasti. Axon degeneration and PGC1α-mediated protection in a vertebrate model of α-synuclein toxicity. 2014
    https://doi.org/10.1242/dmm.013185
  13. Susanne Knorr, Thomas Musacchio, Raik Paulat, Cordula Matthies, Heinz Endres, Nikolaus Wenger, Christoph Harms, Chi Wang Ip. Experimental deep brain stimulation in rodent models of movement disorders. Experimental Neurology 2022;348:113926
    https://doi.org/10.1016/j.expneurol.2021.113926
  14. Joseph Jankovic, Werner Poewe. Therapies in Parkinsonʼs disease. Current Opinion in Neurology 2012;25:433
    https://doi.org/10.1097/WCO.0b013e3283542fc2
  15. Xi Lu, Jeong Sook Kim-Han, Steve Harmon, Shelly E Sakiyama-Elbert, Karen L O'Malley. The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegeneration 2014;9
    https://doi.org/10.1186/1750-1326-9-17
  16. Yasmine Y. Fathy, Laura E. Jonkman, John J. Bol, Evelien Timmermans, Allert J. Jonker, Annemieke J. M. Rozemuller, Wilma D. J. van de Berg. Axonal degeneration in the anterior insular cortex is associated with Alzheimer’s co-pathology in Parkinson’s disease and dementia with Lewy bodies. Transl Neurodegener 2022;11
    https://doi.org/10.1186/s40035-022-00325-x
  17. Christopher D. Herzog, Lamar Brown, Brian R. Kruegel, Alistair Wilson, Malú G. Tansey, Fred H. Gage, Eugene M. Johnson, Raymond T. Bartus. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120). Neurobiology of Disease 2013;58:38
    https://doi.org/10.1016/j.nbd.2013.04.011
  18. A. S. Alexandris, L. Walker, A. K. L. Liu, K. E. McAleese, M. Johnson, R. K. B. Pearce, S. M. Gentleman, J. Attems. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer’s disease and Lewy body disorders. Neuropathology Appl Neurobio 2020;46:264
    https://doi.org/10.1111/nan.12577
  19. Laura J. de Schipper, Anne Hafkemeijer, Mark J.R.J. Bouts, Jeroen van der Grond, Johan Marinus, Johanna M.L. Henselmans, Jacobus J. van Hilten. Age- and disease-related cerebral white matter changes in patients with Parkinson's disease. Neurobiology of Aging 2019;80:203
    https://doi.org/10.1016/j.neurobiolaging.2019.05.004
  20. Jennifer L. Walters, Theresa A. Lansdell, Keith J. Lookingland, Lisa E. Baker. The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats. Toxicology and Applied Pharmacology 2015;289:185
    https://doi.org/10.1016/j.taap.2015.09.026
  21. Zheng Wen, Caiyun Gao, Xuemin Wang, Jing Shi, Bo Tian. Analysis of Cdk5-related Phosphoproteomics in Growth Cones. J Mol Neurosci 2014;52:384
    https://doi.org/10.1007/s12031-013-0162-x
  22. Hugo C. Baggio, Bàrbara Segura, Carme Junque. Resting‐State Functional Brain Networks in Parkinson's Disease. CNS Neurosci Ther 2015;21:793
    https://doi.org/10.1111/cns.12417
  23. Eliseu da Cruz Moreira-Junior. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease. Medical Hypotheses 2019;133:109399
    https://doi.org/10.1016/j.mehy.2019.109399
  24. Raymond T. Bartus, Eugene M. Johnson. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?. Neurobiology of Disease 2017;97:169
    https://doi.org/10.1016/j.nbd.2016.03.026
  25. Sule Tinaz, Peter M. Lauro, Pritha Ghosh, Codrin Lungu, Silvina G. Horovitz. Changes in functional organization and white matter integrity in the connectome in Parkinson's disease. NeuroImage: Clinical 2017;13:395
    https://doi.org/10.1016/j.nicl.2016.12.019
  26. Andrea Terron, Anna Bal-Price, Alicia Paini, Florianne Monnet-Tschudi, Susanne Hougaard Bennekou, Marcel Leist, Stefan Schildknecht. An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition. Arch Toxicol 2018;92:41
    https://doi.org/10.1007/s00204-017-2133-4
  27. Esther Annegret Pelzer, Corina Melzer, Anna Schönberger, Martin Hess, Lars Timmermann, Carsten Eggers, Marc Tittgemeyer. Axonal degeneration in Parkinson's disease – Basal ganglia circuitry and D2 receptor availability. NeuroImage: Clinical 2019;23:101906
    https://doi.org/10.1016/j.nicl.2019.101906
  28. Yanwu Yang, Chenfei Ye, Junyan Sun, Li Liang, Haiyan Lv, Linlin Gao, Jiliang Fang, Ting Ma, Tao Wu. Alteration of brain structural connectivity in progression of Parkinson's disease: A connectome-wide network analysis. NeuroImage: Clinical 2021;31:102715
    https://doi.org/10.1016/j.nicl.2021.102715
  29. Bor Luen Tang. Sirtuins as modifiers of Parkinson's disease pathology. J of Neuroscience Research 2017;95:930
    https://doi.org/10.1002/jnr.23806